• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021

    11/3/21 7:55:00 AM ET
    $INOV
    EDP Services
    Technology
    Get the next $INOV alert in real time by email

    BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry's leading executives and thought leaders discussing the ways in which technology can enable collaborative partnerships to facilitate data sharing and empower patients and their providers.

    A panel of prominent specialty pharmacy experts from AllianceRx Walgreens Prime, AIDS Healthcare Foundation, and Perigon Pharmacy will open the ScriptMed® Conference, sharing their thoughts and futuristic views of the healthcare industry. Additional speakers represent notable organizations including the Walmart, UPMC Health Plan, OneOme, and Carequality, among many others. Additional presentations will be delivered by Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and various pharmacy business leaders at Inovalon.

    "Success in the specialty pharmacy model is measured by patient experience and outcomes," said Matt Brow, president & general manager, pharmacy, life sciences and advisory of Inovalon. "We are honored to bring together leading voices in the industry to discuss how technology, coupled with real-time insights, is enabling a data-driven approach to pharmacy operations, from referral to delivery to ongoing care, that drives greater value and impact for patients as well as improves the overall efficiency and economics of healthcare."

    As sophisticated technology innovation proves a major success factor for advancing patient care, industry leaders at the ScriptMed® Conference will provide timely assessments and insights into the current pharmacy landscape and discuss how data and its analysis is empowering data-driven improvements in patient care, quality outcomes and financial performance across the healthcare ecosystem. Conference attendees include executives from the specialty channel, including specialty pharmacy providers, pharmaceutical manufacturers, health plans, health systems and other stakeholders.

    To learn more about the event and to register, please visit https://www.inovalon.com/scriptmed-conference/.

    About Inovalon

    Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of "Turning Data into Insight, and Insight into Action®." Supporting thousands of customers, including all 25 of the top 25 U.S. health plans, all 25 of the top 25 global pharma companies, 24 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon's technology platforms and analytics are informed by data pertaining to more than one million physicians, 584,000 clinical facilities, 338 million Americans, and 63 billion medical events. For more information, visit www.inovalon.com.

    Contact:

    Justine Giancola        

    Communications Manager

    [email protected]

    813-288-3283



    Primary Logo

    Get the next $INOV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INOV

    DatePrice TargetRatingAnalyst
    8/25/2021Overweight → Sector Weight
    Keybanc
    8/20/2021Buy → Neutral
    BTIG
    7/29/2021$35.00 → $40.00Overweight
    Keybanc
    7/28/2021$35.00 → $45.00Outperform
    SVB Leerink
    More analyst ratings

    $INOV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Teuber William J Jr returned $6,289,892 worth of shares to the company (153,412 units at $41.00) and returned $654,770 worth of Class B Common Stock to the company (15,970 units at $41.00), closing all direct ownership in the company (tax withholding)

    4 - Inovalon Holdings, Inc. (0001619954) (Issuer)

    11/29/21 8:56:03 PM ET
    $INOV
    EDP Services
    Technology

    SEC Form 4: Roberts Lee D returned $5,761,812 worth of shares to the company (140,532 units at $41.00), closing all direct ownership in the company (for withholding tax)

    4 - Inovalon Holdings, Inc. (0001619954) (Issuer)

    11/29/21 8:55:41 PM ET
    $INOV
    EDP Services
    Technology

    SEC Form 4: Pulido Mark gifted 50,000 shares and returned $8,936,401 worth of shares to the company (217,961 units at $41.00), closing all direct ownership in the company to cover taxes

    4 - Inovalon Holdings, Inc. (0001619954) (Issuer)

    11/29/21 8:55:21 PM ET
    $INOV
    EDP Services
    Technology

    $INOV
    SEC Filings

    View All

    SEC Form 15-12B filed by Inovalon Holdings, Inc.

    15-12B - Inovalon Holdings, Inc. (0001619954) (Filer)

    12/6/21 2:59:58 PM ET
    $INOV
    EDP Services
    Technology

    SEC Form S-8 POS filed by Inovalon Holdings, Inc.

    S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)

    11/24/21 11:08:54 AM ET
    $INOV
    EDP Services
    Technology

    SEC Form S-8 POS filed by Inovalon Holdings, Inc.

    S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)

    11/24/21 11:05:54 AM ET
    $INOV
    EDP Services
    Technology

    $INOV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Inovalon Holdings downgraded by Keybanc

    Keybanc downgraded Inovalon Holdings from Overweight to Sector Weight

    8/25/21 4:27:42 AM ET
    $INOV
    EDP Services
    Technology

    Inovalon Holdings downgraded by BTIG

    BTIG downgraded Inovalon Holdings from Buy to Neutral

    8/20/21 5:23:45 AM ET
    $INOV
    EDP Services
    Technology

    Keybanc reiterated coverage on Inovalon Holdings with a new price target

    Keybanc reiterated coverage of Inovalon Holdings with a rating of Overweight and set a new price target of $40.00 from $35.00 previously

    7/29/21 4:39:53 AM ET
    $INOV
    EDP Services
    Technology

    $INOV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Equity Consortium Led by Nordic Capital and Including Insight Partners Completes Acquisition of Inovalon

    BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders of Inovalon. The acquisition was previously announced on August 19, 2021, and was approved by Inovalon's stockholders on November 16, 2021. In accordance with the terms of the agreement, Inovalon stockholders will receive $41.00 in cash for each share of Class A Common Stock and Cla

    11/24/21 9:45:00 AM ET
    $INOV
    EDP Services
    Technology

    Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021

    BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry's leading executives and thought leaders discussing the ways in which technology can enable collaborative partnerships to facilitate data sharing and empower patients and their providers. A panel of prominent specialty pharmacy experts from AllianceRx Walgreens Prime, AIDS Healthcare Foundation, and Perigon Pharmacy will open the ScriptMed® Conference, sharing their thoughts and futuristic vie

    11/3/21 7:55:00 AM ET
    $INOV
    EDP Services
    Technology

    Inovalon to Host Virtual Client Congress October 18-19, 2021

    Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation's most influential voices to address the programs, perspectives, and policies shaping U.S. healthcare and to share insights intended to help organizations thrive in today's dynamic marketplace. This is the second time in thi

    10/13/21 7:55:00 AM ET
    $INOV
    EDP Services
    Technology

    $INOV
    Leadership Updates

    Live Leadership Updates

    View All

    Inovalon Announces Appointment of Eron S. Kelly as Corporate President

    BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon's Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company's multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total cust

    6/28/21 7:55:00 AM ET
    $INOV
    EDP Services
    Technology

    $INOV
    Financials

    Live finance-specific insights

    View All

    Inovalon Reports Second Quarter 2021 Results

    Second Quarter 2021 Highlights Q2 revenue of $190.4 million, up 17% YoY and 8% sequentiallyQ2 subscription-based platform revenue of $168.7 million, up 19% YoY and 7% sequentially, equating to 89% of Q2 total revenueQ2 net income of $9.6 million, resulting in diluted net income of $0.06 per shareQ2 Non-GAAP net income of $27.9 million, resulting in Non-GAAP net income of $0.19 per share, up 27% YoYQ2 Adjusted EBITDA of $64.1 million, up 13% YoY and 9% sequentially, resulting in adjusted EBITDA margin of 33.7%Q2 new sales Annual Contract Value (ACV)1 totaled $60.5 million and platform new sales ACV totaled $43.2 million Debt & Cash Highlights Cash balance as of June 30, 2021 totaling $117.

    7/28/21 4:10:00 PM ET
    $INOV
    EDP Services
    Technology

    $INOV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)

    2/12/21 4:05:46 PM ET
    $INOV
    EDP Services
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)

    2/12/21 4:04:52 PM ET
    $INOV
    EDP Services
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)

    2/10/21 11:04:54 AM ET
    $INOV
    EDP Services
    Technology